Page 216 - Liver Diseases in Children

206 โรคตับในเด็ก

pthaigastro.org
29. Wirth S, Zhang H, Hardikar W, Schwarz KB, Sokal E, Yang W, et al. Efficacy and safety of
peginterferon alfa-2a (40KD) in children with chronic hepatitis B: The PEG-B-ACTIVE Study.

Hepatology 2018.
30. Chien YC, Jan CF, Chiang CJ, Kuo HS, You SL, Chen CJ. Incomplete hepatitis B immunization, maternal
carrier status, and increased risk of liver diseases: a 20-year cohort study of 3.8 million vaccinees.
Hepatology 2014;60:125-32.
31. Poovorawan Y, Theamboonlers A, Sanpavat S, Chongsrisawat V, Willems P, Safary A. Comparison
study of combined DTPw-HB vaccines and separate administration of DTPw and HB vaccines in Thai
children. Asian Pac J Allergy Immunol 1999;17:113-20.

32. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Crasta PD, Messier M, Hardt K. Long-term anti-HBs
antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic
response: a 20-year follow-up study in Thailand. Hum Vaccin Immunother 2013;9:1679-84.
33. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Bock HL, Leyssen M, Jacquet JM. Persistence of
antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand.
Vaccine 2010;28:730-6.
34. Chongsrisawat V, Theamboonlers A, Khwanjaipanich S, Owatanapanich S, Sinlaparatsamee S,
Poovorawan Y. Humoral immune response following hepatitis B vaccine booster dose in children with
and without prior immunization. Southeast Asian J Trop Med Public Health 2000;31:623-6.

35. Sintusek P, Posuwan N, Wanawongsawad P, Jitraruch S, Poovorawan Y, Chongsrisawat V. High
prevalence of hepatitis B-antibody loss and a case report of de novo hepatitis B virus infection in a
child after living-donor liver transplantation. World J Gastroenterol 2018;24:752-62.
36. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Leroux-Roels G, Kuriyakose S, Leyssen M, et al.
Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination
in a high endemicity region. J Viral Hepat 2011;18:369-75.
37. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Vimolkej L, Yano M. Is there evidence for

intrauterine HBV infection in newborns of hepatitis B carrier mothers? Southeast Asian J Trop Med
Public Health 1997;28:365-9.
38. Poovorawan Y, Theamboonlers A, Chongsrisawat V, Sanpavat S. Molecular analysis of the a determinant
of HBsAg in children of HBeAg-positive mothers upon failure of postexposure prophylaxis. Int J Infect
Dis 1998;2:216-20.
39. Jourdain G, Ngo-Giang-Huong N, Harrison L, Decker L, Khamduang W, Tierney C, et al. Tenofovir
versus placebo to prevent perinatal transmission of hepatitis B. N Engl J Med 2018;378:911-23.
40. Sellier PO, Maylin S, Brichler S, Bercot B, Lopes A, Chopin D, et al. Hepatitis B virus-hepatitis D virus
mother-to-child co-transmission: a retrospective study in a developed country. Liver Int 2018;38:611-8.

41. Xue MM, Glenn JS, Leung DH. Hepatitis D in children. J Pediatr Gastroenterol Nutr 2015;61:271-81.